| 000 | 01807 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517165325.0 | ||
| 264 | 0 | _c20171207 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1066-2936 | ||
| 024 | 7 |
_a10.22462/1.2.2017.6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Ying | |
| 245 | 0 | 0 |
_aOridonin protects the lung against hyperoxia-induced injury in a mouse model. _h[electronic resource] |
| 260 |
_bUndersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc _c |
||
| 300 |
_a33-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcute Lung Injury _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAtmospheric Pressure |
| 650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xchemistry |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDiterpenes, Kaurane _xtherapeutic use |
| 650 | 0 | 4 |
_aGlutathione _xanalysis |
| 650 | 0 | 4 |
_aInterleukin-10 _xanalysis |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xanalysis |
| 650 | 0 | 4 |
_aLung _xchemistry |
| 650 | 0 | 4 |
_aMalondialdehyde _xanalysis |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOxygen _xadverse effects |
| 650 | 0 | 4 | _aPartial Pressure |
| 650 | 0 | 4 |
_aProtective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aPulmonary Edema _xdrug therapy |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTumor Necrosis Factor-alpha |
| 700 | 1 | _aZhang, Pei-Xi | |
| 700 | 1 | _aHan, Cui-Hang | |
| 700 | 1 | _aWei, Dunbiao | |
| 700 | 1 | _aQiao, Tongju | |
| 700 | 1 | _aPeng, Bo | |
| 700 | 1 | _aLiu, Kan | |
| 700 | 1 | _aZheng, Juan | |
| 700 | 1 | _aLiu, Wenwu | |
| 773 | 0 |
_tUndersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc _gvol. 44 _gno. 1 _gp. 33-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.22462/1.2.2017.6 _zAvailable from publisher's website |
| 999 |
_c27426285 _d27426285 |
||